Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Adoption of Connected Healthcare Solutions to Improve Patient Adherence and Compliance
* Required Fields
Pay by invoice
The growing interest in drug delivery devices is more towards micro needle technology for vaccines and hormones. As healthcare companies focus on the transdermal mode of delivery for insulin, companies developing patch technologies have also received huge funding, indicating that the interest in the industry is shifting toward transdermal drug delivery. Great emphasis is being placed on the targeted drug delivery system to help minimize the probability of adverse effects. This system ensures reachability with enhanced efficacy and minimal degradation bypassing the body’s defense mechanisms.Expanding patient populations and growing unmet medical needs are contributing to a higher demand for healthcare services and leading to increased cost pressures within global healthcare systems. Steadily rising healthcare costs have also led to increased scrutiny on drug pricing by governments, the media, and consumers. In this context, it is understandable that extending the use of generics is considered an important element in most prescribing strategies to achieve substantial savings without impacting patient care. Switching from branded inhaled drugs to lower-cost generics represents an opportunity to reduce the cost of treatments for asthma and chronic obstructive pulmonary disease (COPD).One challenge posed by the new generations of biologics is that many of them are large molecules and have to be administered in high concentrations. The resulting formulations reach high viscosities, sometimes together with high volumes, thus creating a challenge for traditional delivery systems. As a result, large-volume wearable injectors, which are worn on the skin, have gained increasing interest within the pharmaceutical industry.For existing companies, the real question is how to transform a seemingly simple delivery device into a technology-fueled, infection-free, and sleek connected environment.A true smart hospital focuses on three major areas – operational efficiency, clinical excellence, and patient-centricity, with technological advances being leveraged for these 3 areas to derive the ‘smart’ insight, which was not possible earlier. Effective drug delivery devices must also provide patient-centric services that are aligned to clinical outcomes. Currently, the major challenges for the adoption of this concept, apart from the obvious need for financial investments, include the same ones that apply to digitization of healthcare – the absolute need for interoperability, the risk of cybersecurity, and the lack of expert resources. Hospitals currently struggle with the major question of where to begin. A detailed, comprehensive solution set needs to be formulated for the hospitals as a strategy plan, and small parts of the solution may be applied, keeping the systems open and interoperable for future solutions to be easily integrated.Author: Bejoy Daniel
Global Neonatal Care Device Market. Forecast to 2023
Innovations in Ophthalmic, Rehabilitation, Cardiovascular and Cancer Screening Devices
Global Blockchain Technology Market in the Healthcare Industry, 2018–2022
Global Enterprise Imaging Solutions Market, Forecast to 2024
Technological Advances in Biobetter and Biosimilar Platforms
Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington's Disease and Amyotrophic Lateral Sclerosis (HD & ALS)
Innovations for the Management of Cancer, Cardiovascular, and Neurological Diseases
Innovations in Sensors, Quantum Dot Displays, Virtual Assistants, Cyber Analytics Tools, Artificial Intelligence, and Brain-computer Interfaces
Innovations in Patient Monitoring, Wearables, Clinical Trial, Ophthalmic Devices, and Medical Image Management
Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
solar cell market
consumer drone market
commercial aviation market
smart grid market
alternative energy market
commercial uav market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.